Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Drug Use-results Survey (All-Case Surveillance) on Prizbind® for Intravenous Solution 2.5 g in Japan

NCT02946931 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT02946931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02946931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Drug Use-results Survey (All-Case Surveillance) on Prizbind® for Intravenous Solution 2.5 g in Japan
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
November 18, 2016
Completion date
November 3, 2020
Enrollment
1,402 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhage